logo

Insys Therapeutics, Inc. (INSY)



Trade INSY now with
  Date
  Headline
8/30/2018 6:04:19 AM INSYS Says FDA Grants Fast Track Designation For Epinephrine Nasal Spray As Investigational Treatment For Anaphylaxis
8/8/2018 7:04:52 AM INSYS Therapeutics Reaches Agreement In Principle To Settle Department Of Justice Investigation
4/27/2018 8:05:26 AM INSYS Therapeutics Begins Phase 2 Clinical Trial Of Cannabidiol For Treatment Of Prader-Willi Syndrome
4/18/2018 8:34:57 AM INSYS Therapeutics Plans To Advance Clinical Research Of Dronabinol Inhalation Using Novel Breath-Actuated Device
4/2/2018 8:34:42 AM INSYS Therapeutics Appoints Trudy Vanhove As A New Independent Member Of Board
3/2/2018 8:33:01 AM INSYS Therapeutics Begins Phase 3 Clinical Trial Of Cannabidiol Oral Solution For Treatment Of Infantile Spasms
2/1/2018 11:06:13 PM INSYS Therapeutics Addresses New York Attorney General’s Complaint
11/4/2016 9:22:13 AM RBC Capital Markets Is Raising Insys Therapeutics, Inc. (INSY) Q4 16 Estimate To -0.02 From -0.09
11/4/2016 9:22:01 AM RBC Capital Markets Is Cutting Insys Therapeutics, Inc. (INSY) 2018 Estimate To 0.96 From 1.38
11/4/2016 9:21:50 AM RBC Capital Markets Is Cutting Insys Therapeutics, Inc. (INSY) 2017 Estimate To 0.31 From 0.78
  
 
>